Response to the Letter from Professor C. R. Wolf and colleagues concerning CRT, 55: 549-586, 2025: The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome-proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation.